scispace - formally typeset
Open AccessJournal ArticleDOI

Germline risk of clonal haematopoiesis

Reads0
Chats0
TLDR
In this paper, the authors synthesize what is currently known about how inherited variation shapes the risk of clonal haematopoiesis and how this genetic architecture intersects with the biology of diseases that occur with ageing.
Abstract
Clonal haematopoiesis (CH) is a common, age-related expansion of blood cells with somatic mutations that is associated with an increased risk of haematological malignancies, cardiovascular disease and all-cause mortality. CH may be caused by point mutations in genes associated with myeloid neoplasms, chromosomal copy number changes and loss of heterozygosity events. How inherited and environmental factors shape the incidence of CH is incompletely understood. Even though the several varieties of CH may have distinct phenotypic consequences, recent research points to an underlying genetic architecture that is highly overlapping. Moreover, there are numerous commonalities between the inherited variation associated with CH and that which has been linked to age-associated biomarkers and diseases. In this Review, we synthesize what is currently known about how inherited variation shapes the risk of CH and how this genetic architecture intersects with the biology of diseases that occur with ageing.

read more

Content maybe subject to copyright    Report

Citations
More filters
Journal ArticleDOI

Somatic Mutations in Cardiovascular Disease

- 07 Jan 2022 - 
TL;DR: In this article , the authors provide an overview of somatic mutations and their contributions to CVD, focusing on the most common and well-described manifestation, clonal hematopoiesis of indeterminate potential.
Journal ArticleDOI

Clonal Hematopoiesis, Somatic Mosaicism, and Age-Associated Disease.

TL;DR: An up-to-date review of clonal hematopoiesis within the context somatic mosaicism and aging is provided and recent epidemiological studies which have reported associations with age-related disease are described.
Journal ArticleDOI

Modeling clonal hematopoiesis in umbilical cord blood cells by CRISPR/Cas9.

TL;DR: In this paper, site-specific mutations were introduced in defined regions of DNMT3A, TET2, and ASXL1 in CD34+ progenitor cells that were subsequently analyzed in short-term as well as long-term in vitro culture assays to assess self-renewal and differentiation capacities.
Journal ArticleDOI

Germline CHEK2 and ATM Variants in Myeloid and Other Hematopoietic Malignancies

TL;DR: The role that deleterious germline CHEK2 and ATM variants play in the development of hematopoietic malignancies is reviewed, and how this influences clinical practice, including cancer screening, hematoplastic stem cell transplantation, and therapy choice is reviewed.
References
More filters
Journal Article

p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition.

TL;DR: The cancer phenotype in theCHK2-families was not characteristic of LFS, and may indicate variable phenotypic expression in the rare families with CHK2 mutations, as additional work is necessary to completely unravel the molecular background of L FS.
Journal ArticleDOI

Aberrations of the MRE11-RAD50-NBS1 DNA damage sensor complex in human breast cancer: MRE11 as a candidate familial cancer-predisposing gene.

TL;DR: It is proposed that germline mutations qualify MRE11 as a novel candidate breast cancer susceptibility gene in a subset of non‐BRCA1/2 families and have implications for the concept of the DNA damage response as an intrinsic anti‐cancer barrier.
Trending Questions (1)
What is a germline clone?

A germline clone refers to a population of cells in the body that have the same genetic makeup inherited from the germline (sperm or egg cells).